Related references
Note: Only part of the references are listed.Role of mitochondrial dysfunction in insulin resistance
Jeong-A Kim et al.
CIRCULATION RESEARCH (2008)
Aliskiren, a novel renin inhibitor, is renoprotective in a model of advanced diabetic nephropathy in rats
D. J. Kelly et al.
DIABETOLOGIA (2007)
Mineralocorticoid receptor blockade attenuates chronic overexpression of the renin-angiotensin-aldosterone system stimulation of reduced nicotinamide adenine dinucleotide phosphate oxidase and cardiac remodeling
Sameer Stas et al.
ENDOCRINOLOGY (2007)
Angiotensin II-mediated oxidative stress promotes myocardial tissue remodeling in the transgenic (mRen2) 27 Ren2 rat
Adam Whaley-Connell et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2007)
Rosuvastatin, a 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor, decreases cardiac oxidative stress and remodeling in Ren2 transgenic rats
Javad Habibi et al.
ENDOCRINOLOGY (2007)
Aliskiren reduces blood pressure and suppresses plasma renin activity in combination with a thiazide diuretic, an angiotensin-converting enzyme inhibitor, or an angiotensin receptor blocker
Eoin O'Brien et al.
HYPERTENSION (2007)
Renin inhibition with aliskiren provides additive anti hypertensive efficacy when used in combination with hydrochlorothiazide
Alberto Villamil et al.
JOURNAL OF HYPERTENSION (2007)
Aliskiren, an orally effective renin inhibitor, provides antihypertensive efficacy alone and in combination with valsartan
James L. Pool et al.
AMERICAN JOURNAL OF HYPERTENSION (2007)
ERK1/2 regulates ANG II-dependent cell proliferation via cytoplasmic activation of RSK2 and nuclear activation of elk1
Michael D. Godeny et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2006)
Association of RhoGDIα with Rac1 GTPase mediates free radical production during myocardial hypertrophy
Florian Custodis et al.
CARDIOVASCULAR RESEARCH (2006)
Cardiac mast cell-derived renin promotes local angiotensin formation, norepinephrine release, and arrhythmias in ischemia/reperfusion
CJ Mackins et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
The Rac and Rho hall of fame - A decade of hypertrophic signaling hits
JH Brown et al.
CIRCULATION RESEARCH (2006)
NADPH oxidase is involved in angiotensin II-induced apoptosis in H9C2 cardiac muscle cells: Effects of apocynin
FZ Qin et al.
FREE RADICAL BIOLOGY AND MEDICINE (2006)
Increased aortic NADPH oxidase activity in rats with genetically high angiotensin-converting enzyme levels
JE Jalil et al.
HYPERTENSION (2005)
Aliskiren, a human renin inhibitor, ameliorates cardiac and renal damage in double-transgenic rats
B Pilz et al.
HYPERTENSION (2005)
Oxygen, oxidative stress, hypoxia, and heart failure
FJ Giordano
JOURNAL OF CLINICAL INVESTIGATION (2005)
Aliskiren, a novel, orally effective renin inhibitor, lowers blood pressure in marmosets and spontaneously hypertensive rats
JM Wood et al.
JOURNAL OF HYPERTENSION (2005)
Pressure-independent effects of angiotensin II on hypertensive myocardial fibrosis
K Tokuda et al.
HYPERTENSION (2004)
Extracellular signal regulated kinase and SMAD signaling both mediate the angiotensin II driven progression towards overt heart failure in homozygous TGR(mRen2)27
RA de Boer et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2004)
The superoxide dismutase mimetic, tempol, blunts right ventricular hypertrophy in chronic hypoxic rats
B Elmedal et al.
BRITISH JOURNAL OF PHARMACOLOGY (2004)
Redox regulation angiotensin II signalling in trhe heart
DK Das et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2004)
AT1 blockade prevents glucose-induced cardiac dysfunction in ventricular myocytes -: Role of the AT1 receptor and NADPH oxidase
JR Privratsky et al.
HYPERTENSION (2003)
NADPH oxidase-derived superoxide anion mediates angiotensin II-induced cardiac hypertrophy
H Nakagami et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2003)
Divergent roles of angiotensin II AT1 and AT2 receptors in modulating coronary microvascular function
CH Zhang et al.
CIRCULATION RESEARCH (2003)
Cardiac fibrosis occurs early and involves endothelin and AT-1 receptors in hypertension due to endogenous angiotensin II
TM Seccia et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2003)
Spironolactone improves angiotensin-induced vascular changes and oxidative stress
A Virdis et al.
HYPERTENSION (2002)
Pivotal role of a gp91phox-containing NADPH oxidase in angiotensin II-induced cardiac hypertrophy in mice
JK Bendall et al.
CIRCULATION (2002)
Vascular endothelial growth factor induces manganese-superoxide dismutase expression in endothelial cells by a Rac1-regulated NADPH oxidase-dependent mechanism
MR Abid et al.
FASEB JOURNAL (2001)
Human cells are protected from mitochondrial dysfunction by complementation of DNA products in fused mitochondria
T Ono et al.
NATURE GENETICS (2001)
Canine ventricular myocytes possess a renin-angiotensin system that is upregulated with heart failure
L Barlucchi et al.
CIRCULATION RESEARCH (2001)
Reduction in left ventricular messenger RNA for transforming growth factor β1 attenuates left ventricular fibrosis and improves survival without lowering blood pressure in the hypertensive TGR(mRen2)27 rat
YM Pinto et al.
HYPERTENSION (2000)
Structure-based drug design:: the discovery of novel nonpeptide orally active inhibitors of human renin
J Rahuel et al.
CHEMISTRY & BIOLOGY (2000)
Blockade of angiotensin II type 1 receptor and not of endothelin receptor prevents hypertension and cardiovascular disease in transgenic (mREN2)27 rats via adrenocortical steroid-independent mechanisms
GP Rossi et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2000)
Share Paper
